Effect of skip lymphovascular invasion on hepatic metastasis in colorectal carcinomas

Verfasser / Beitragende:
[Yosuke Okamoto, Hiroyuki Mitomi, Kazuhito Ichikawa, Shigeki Tomita, Takahiro Fujimori, Yoshinori Igarashi]
Ort, Verlag, Jahr:
2015
Enthalten in:
International Journal of Clinical Oncology, 20/4(2015-08-01), 761-766
Format:
Artikel (online)
ID: 605491100
LEADER caa a22 4500
001 605491100
003 CHVBK
005 20210128100508.0
007 cr unu---uuuuu
008 210128e20150801xx s 000 0 eng
024 7 0 |a 10.1007/s10147-014-0778-z  |2 doi 
035 |a (NATIONALLICENCE)springer-10.1007/s10147-014-0778-z 
245 0 0 |a Effect of skip lymphovascular invasion on hepatic metastasis in colorectal carcinomas  |h [Elektronische Daten]  |c [Yosuke Okamoto, Hiroyuki Mitomi, Kazuhito Ichikawa, Shigeki Tomita, Takahiro Fujimori, Yoshinori Igarashi] 
520 3 |a Background: "Skip” lymphovascular invasion presenting as discontinuous foci of tumor cells within the colon wall is now excluded from consideration when determining T stage in the TNM classification. The purpose of this study was to assess the clinicopathological characteristics of colorectal cancer (CRC) patients with such skip lymphovascular invasion. Methods: First, a retrospective questionnaire survey of the incidence of skip lymphovascular invasion was performed for a total of 1,868 patients with CRCs at ten institutions. Next, we comparatively assessed clinicopathological data for 896 CRC patients with or without skip lymphovascular invasion. Results: The incidence of skip lymphovascular invasion was 1.1% (20 out of 1,868). Most of the affected cases were rectal, pT2, and node negative, with moderately differentiated histology. Skip lymphovascular invasion was present in the muscularis propria and subserosa, with the tumors directly invading submucosa (pT1) or muscularis propria (pT2). Hepatic metastasis was greater in CRC with skip lymphovascular invasion (25%) than in pT1/2 CRC (0%; P<0.001) or pT3 CRC without such invasion (13.8%; P=0.185). Conclusions: Our study suggests that skip lymphovascular invasion is associated with hepatic metastasis in CRC cases. Thus, definition of a T category including such invasion would be useful for clinical practice. 
540 |a Japan Society of Clinical Oncology, 2014 
690 7 |a Skip metastasis  |2 nationallicence 
690 7 |a Lymphovascular invasion  |2 nationallicence 
690 7 |a Colon carcinoma  |2 nationallicence 
690 7 |a Liver metastasis  |2 nationallicence 
700 1 |a Okamoto  |D Yosuke  |u Division of Gastroenterology and Hepatology, Department of Internal Medicine, Toho University Omori Medical Center, 6-11-1 Omorinishi, Ota-ku, 143-8541, Tokyo, Japan  |4 aut 
700 1 |a Mitomi  |D Hiroyuki  |u Department of Surgical and Molecular Pathology, Dokkyo Medical University School of Medicine, 880 Kitakobayashi, Mibu, 321-0293, Shimotsuga, Tochigi, Japan  |4 aut 
700 1 |a Ichikawa  |D Kazuhito  |u Regional Medical Support Center, Fukushima Medical University, 1 Hikarigaoka, 960-1295, Fukushima, Fukushima, Japan  |4 aut 
700 1 |a Tomita  |D Shigeki  |u Department of Pathology, Juntendo University Urayasu Hospital, 2-1-1 Tomioka, 279-0021, Urayasu, Chiba, Japan  |4 aut 
700 1 |a Fujimori  |D Takahiro  |u Department of Pathology, Shinko Hospital, 1-4-47 Wakihama-cho, Chuo-ku, 651-0072, Kobe, Hyogo, Japan  |4 aut 
700 1 |a Igarashi  |D Yoshinori  |u Division of Gastroenterology and Hepatology, Department of Internal Medicine, Toho University Omori Medical Center, 6-11-1 Omorinishi, Ota-ku, 143-8541, Tokyo, Japan  |4 aut 
773 0 |t International Journal of Clinical Oncology  |d Springer Japan  |g 20/4(2015-08-01), 761-766  |x 1341-9625  |q 20:4<761  |1 2015  |2 20  |o 10147 
856 4 0 |u https://doi.org/10.1007/s10147-014-0778-z  |q text/html  |z Onlinezugriff via DOI 
898 |a BK010053  |b XK010053  |c XK010000 
900 7 |a Metadata rights reserved  |b Springer special CC-BY-NC licence  |2 nationallicence 
908 |D 1  |a research-article  |2 jats 
949 |B NATIONALLICENCE  |F NATIONALLICENCE  |b NL-springer 
950 |B NATIONALLICENCE  |P 856  |E 40  |u https://doi.org/10.1007/s10147-014-0778-z  |q text/html  |z Onlinezugriff via DOI 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Okamoto  |D Yosuke  |u Division of Gastroenterology and Hepatology, Department of Internal Medicine, Toho University Omori Medical Center, 6-11-1 Omorinishi, Ota-ku, 143-8541, Tokyo, Japan  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Mitomi  |D Hiroyuki  |u Department of Surgical and Molecular Pathology, Dokkyo Medical University School of Medicine, 880 Kitakobayashi, Mibu, 321-0293, Shimotsuga, Tochigi, Japan  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Ichikawa  |D Kazuhito  |u Regional Medical Support Center, Fukushima Medical University, 1 Hikarigaoka, 960-1295, Fukushima, Fukushima, Japan  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Tomita  |D Shigeki  |u Department of Pathology, Juntendo University Urayasu Hospital, 2-1-1 Tomioka, 279-0021, Urayasu, Chiba, Japan  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Fujimori  |D Takahiro  |u Department of Pathology, Shinko Hospital, 1-4-47 Wakihama-cho, Chuo-ku, 651-0072, Kobe, Hyogo, Japan  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Igarashi  |D Yoshinori  |u Division of Gastroenterology and Hepatology, Department of Internal Medicine, Toho University Omori Medical Center, 6-11-1 Omorinishi, Ota-ku, 143-8541, Tokyo, Japan  |4 aut 
950 |B NATIONALLICENCE  |P 773  |E 0-  |t International Journal of Clinical Oncology  |d Springer Japan  |g 20/4(2015-08-01), 761-766  |x 1341-9625  |q 20:4<761  |1 2015  |2 20  |o 10147